Patent Term Application for AUCATZYL (obecabtagene autoleucel), Patent No. 11,578,126 | Federal Regulations · Congress.wiki

Nonrulemaking

FDA

FDA-2025-E-0361

Patent Term Application for AUCATZYL (obecabtagene autoleucel), Patent No. 11,578,126

Documents

Comments

Description

OPEN

Comment Period OpensFeb 4, 2025

Comment Period ClosesApr 15, 2026

Type	Title	Posted	Comments	Status
Notice	Determination of Regulatory Review Period for Purposes of Patent Extension; AUCATZYL FR Doc: 2026-02972	Feb 13, 2026	--

CDER

Patent Term Application for AUCATZYL

Marshall, Gerstein & Borun, LLP

Autolus Limited

(obecabtagene autoleucel)

Patent No. 11,578,126

OPEN